Skip to main content
NCBI home page
Gut logoLink to Gut
. 1990 Sep;31(9):968–972. doi: 10.1136/gut.31.9.968

Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations.

C M Bate 1, P W Keeling 1, C O'Morain 1, S P Wilkinson 1, D N Foster 1, R A Mountford 1, J M Temperley 1, R F Harvey 1, D G Thompson 1, M Davis 1, et al.
PMCID: PMC1378649  PMID: 2210463

Abstract

Symptomatic patients with endoscopically verified reflux oesophagitis were randomised to a double blind trial in which they received either omeprazole (20 mg once daily) or cimetidine (400 mg four times daily) for four, and if necessary, eight weeks. In an 'intention to treat' analysis, oesophagitis was found to have healed after four weeks in 77 of 137 (56%) in the omeprazole group and in 34 of 133 (26%) in the cimetidine group (p less than 0.001). By eight weeks these values were 71% and 35% respectively; p less than 0.001. Histological assessments were available for 73% of the patients. At entry, 63% (66 of 104) in the omeprazole group and 60% (56 of 94) in the cimetidine group (ns) had abnormal histology. After the study, the proportions of patients who initially had had abnormal histology but who then progressed to normal were 67% (44 of 66: omeprazole) and 48% (27 of 56: cimetidine) respectively (p less than 0.001). All patients had reflux symptoms at entry. After four weeks, 46% in the omeprazole group and 22% (p less than 0.001) in the cimetidine group were asymptomatic. Diary cards completed for the first two weeks showed that patients treated with omeprazole experienced fewer reflux symptoms by day and night and used fewer antacids. Omeprazole, 20 mg once a day for four to eight weeks, healed a greater proportion of patients with reflux oesophagitis than cimetidine, 1.6 g per day, assessed endoscopically and histologically, and relieved more patients' symptoms.

Full text

PDF
968

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bate C. M., Wilkinson S. P., Bradby G. V., Bateson M. C., Hislop W. S., Crowe J. P., Willoughby C. P., Peers E. M., Richardson P. D. Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer. Gut. 1989 Oct;30(10):1323–1328. doi: 10.1136/gut.30.10.1323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Crowe J. P., Wilkinson S. P., Bate C. M., Willoughby C. P., Peers E. M., Richardson P. D. Symptom relief and duodenal ulcer healing with omeprazole or cimetidine. Opus (Omeprazole Peptic Ulcer Study) Research Group. Aliment Pharmacol Ther. 1989 Feb;3(1):83–91. doi: 10.1111/j.1365-2036.1989.tb00193.x. [DOI] [PubMed] [Google Scholar]
  3. Funch-Jensen P., Kock K., Christensen L. A., Fallingborg J., Kjaergaard J. J., Andersen S. P., Teglbjaerg P. S. Microscopic appearance of the esophageal mucosa in a consecutive series of patients submitted to upper endoscopy. Correlation with gastroesophageal reflux symptoms and macroscopic findings. Scand J Gastroenterol. 1986 Jan;21(1):65–69. doi: 10.3109/00365528609034624. [DOI] [PubMed] [Google Scholar]
  4. Havelund T., Laursen L. S., Skoubo-Kristensen E., Andersen B. N., Pedersen S. A., Jensen K. B., Fenger C., Hanberg-Sørensen F., Lauritsen K. Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial. Br Med J (Clin Res Ed) 1988 Jan 9;296(6615):89–92. doi: 10.1136/bmj.296.6615.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hetzel D. J., Dent J., Reed W. D., Narielvala F. M., Mackinnon M., McCarthy J. H., Mitchell B., Beveridge B. R., Laurence B. H., Gibson G. G. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology. 1988 Oct;95(4):903–912. doi: 10.1016/0016-5085(88)90162-x. [DOI] [PubMed] [Google Scholar]
  6. McFarland R. J., Bateson M. C., Green J. R., O'Donoghue D. P., Dronfield M. W., Keeling P. W., Burke G. J., Dickinson R. J., Shreeve D. R., Peers E. M. Omeprazole provides quicker symptom relief and duodenal ulcer healing than ranitidine. Gastroenterology. 1990 Feb;98(2):278–283. doi: 10.1016/0016-5085(90)90815-i. [DOI] [PubMed] [Google Scholar]
  7. Sandmark S., Carlsson R., Fausa O., Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study. Scand J Gastroenterol. 1988 Jun;23(5):625–632. doi: 10.3109/00365528809093923. [DOI] [PubMed] [Google Scholar]
  8. Vantrappen G., Rutgeerts L., Schurmans P., Coenegrachts J. L. Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis. Dig Dis Sci. 1988 May;33(5):523–529. doi: 10.1007/BF01798351. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES